Related Experiment Videos
Microbiology of pneumonia in the patient at risk
Abstract:
Microorganisms causing pulmonary infections in high risk patients vary considerably with the predisposing illness (immunosuppression, alcoholism, or diabetes), the setting (nosocomial or community-acquired), and previous therapy (antibiotics, surgery, and inhalation therapy). Even in the immunocompromised patient, conventional bacteria are the most prevalent opportunistic pathogens, and gram-positive cocci such as staphylococci and gram-negative bacilli such as Escherichia coli cause most pneumonias. Fungi, viruses, and protozoa also cause pulmonary infections, but they vary in frequency from one institution to another. Diagnostic proof of the etiology of pulmonary infection is often difficult to obtain. The microbial flora of sputum is not definitive and must be confirmed by blood or pleural fluid culture, antigen or serologic response in body fluids, or morphologic presence in lung tissue. Resistance to antimicrobial therapy is increasing, especially among nosocomially acquired gram-negative bacilli and methicillin-resistant staphylococci. A potential for increased resistance exists in pneumococcal, viral, and fungal infection but is not yet apparent in pulmonary infections due to protozoal pathogens. Tests to predict antibiotic response such as serum bactericidal assay, repeated cultures, and serologic studies are helpful but correlate imperfectly with clinical outcome.
Insights
Pulmonary infections in high-risk patients are caused by diverse microbes, with bacteria being most common. Diagnostic challenges and increasing antimicrobial resistance complicate treatment strategies for these infections.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Pulmonary infections in high-risk patients present diverse etiologies influenced by predisposing conditions, healthcare settings, and prior treatments.
- Conventional bacteria, including staphylococci and Escherichia coli, are the predominant opportunistic pathogens, even in immunocompromised individuals.
- Fungal, viral, and protozoal infections also contribute to pulmonary disease, with institutional prevalence varying.
Purpose of the Study:
- To review the spectrum of microorganisms causing pulmonary infections in high-risk patients.
- To highlight diagnostic challenges and the increasing issue of antimicrobial resistance.
- To discuss the utility and limitations of tests predicting antibiotic response.
Main Methods:
- Literature review of studies on pulmonary infections in high-risk populations.
- Analysis of causative agents based on patient risk factors, infection setting, and prior therapies.
- Evaluation of diagnostic methods and antimicrobial resistance patterns.
Main Results:
- Bacterial pathogens, particularly Gram-positive cocci and Gram-negative bacilli, are the most frequent causes of pneumonia in high-risk groups.
- Diagnostic confirmation often requires methods beyond sputum analysis, such as blood cultures or tissue examination.
- Antimicrobial resistance is a growing concern, especially with nosocomial Gram-negative bacilli and methicillin-resistant staphylococci.
Conclusions:
- Effective management of pulmonary infections in high-risk patients requires accurate etiologic diagnosis and consideration of evolving resistance patterns.
- While conventional bacteria are primary pathogens, other microorganisms must be considered.
- Predictive tests for antibiotic response offer guidance but imperfectly correlate with clinical outcomes, necessitating careful clinical judgment.